Most HPV infections in men are not permanent. The median time to clearance is about 6 months, and roughly 75% of infections clear within 12 months. However, the full picture is more nuanced than a simple yes or no, because a small percentage of infections do persist, and emerging evidence suggests the virus may linger in a dormant state even after it becomes undetectable.
How Quickly Most Men Clear HPV
The immune system handles HPV the way it handles many viral infections: it identifies infected cells and eliminates them over a period of weeks to months. In men, the median clearance time for any HPV type is 5.9 months. That means half of all infections are gone in under six months, and three out of four are cleared within a year. Penile infections tend to clear faster than anal infections, likely because the skin of the penis is more exposed to immune surveillance than the lining of the anal canal.
During this window, you typically won’t know you’re infected. Most HPV infections in men produce no symptoms at all. Low-risk strains (the types that cause genital warts) sometimes make themselves visible, but high-risk strains, the ones linked to cancer, almost never do.
High-Risk Strains Take Longer to Clear
Not all HPV types behave the same way. High-risk strains like HPV 16 and 18 persist significantly longer than low-risk strains. One study found the median clearance time for high-risk infections in men was dramatically longer than for low-risk infections, and having a low-risk type was independently associated with faster clearance. This matters because the longer a high-risk strain sticks around, the greater the chance it causes cellular changes that can eventually lead to cancer.
The infections that don’t clear within one to two years are considered “persistent.” Persistent infection is the key risk factor for HPV-related cancers in men. Still, even persistence doesn’t guarantee cancer. It means the risk is elevated enough to warrant attention.
The Question of Viral Latency
Here’s where things get complicated. “Clearance” in clinical terms means the virus is no longer detectable in tissue samples. But detectable and gone are not the same thing. Research on viral latency shows that HPV DNA can persist in a small number of basal cells (the deepest layer of the skin) even after visible lesions disappear and tests come back negative.
These latent infections involve very limited viral gene activity. The virus is essentially dormant, not replicating enough to cause disease or show up on tests. But it’s still there. Mechanical irritation, inflammation, or a weakened immune system can reactivate it, potentially leading to a new detectable infection or the reappearance of warts. This is why some men experience what feels like a “new” HPV infection years later, when it may actually be a reactivation of the original one.
So while most men’s immune systems suppress HPV effectively and permanently, there is credible evidence that the virus isn’t always fully eradicated from the body. It may instead be controlled to the point of being functionally irrelevant, similar to how the chickenpox virus remains dormant in nerve cells for life.
Cancer Risk From Persistent Infections
According to CDC data from 2018 to 2022, approximately 22,827 HPV-associated cancers were diagnosed in men in the United States each year. The most common was oropharyngeal cancer (cancers of the back of the throat, base of the tongue, and tonsils), followed by anal cancer and penile cancer. An estimated 79% of all HPV-associated cancers were directly attributable to the virus.
These cancers are overwhelmingly linked to persistent high-risk HPV infections, particularly HPV 16. About 90% of anal cancers, 70% of oropharyngeal cancers, and 60% of penile cancers are HPV-positive. The progression from persistent infection to cancer is slow, typically taking years to decades, which is why these cancers tend to appear in middle-aged and older men rather than in the years immediately following infection.
No Approved Screening Test for Men
One of the most frustrating aspects of HPV in men is the lack of diagnostic tools. There is no FDA-approved HPV test for men, and the CDC does not recommend routine HPV screening for men. The reasons include the extremely high prevalence of infection (testing would flag millions of men with infections that will resolve on their own), the absence of a validated test for non-cervical sites, and the fact that there’s no specific treatment for the infection itself. You can treat the consequences of HPV, like warts or precancerous cells, but not the underlying virus.
This means most men never know their HPV status. If you have genital warts, a doctor can diagnose them visually. If you develop symptoms like a persistent sore throat, difficulty swallowing, or unusual lumps, those warrant evaluation. But there is no equivalent of the Pap smear or cervical HPV test for men.
Vaccination Makes a Major Difference
The HPV vaccine is the single most effective tool for preventing persistent infections in men. In clinical trials, vaccination reduced persistent infections from HPV types 6, 11, 16, and 18 by 85.6%. That’s not just preventing initial infection; it’s specifically preventing the kind of long-lasting infection that leads to cancer and warts.
The vaccine is approved for males through age 45, though it’s most effective when given before any exposure to the virus, ideally between ages 9 and 14. If you’ve already been infected with one HPV type, the vaccine still protects against the other types it covers. It won’t treat an existing infection, but it can prevent new ones.
Transmission After the Virus Clears
Even after warts disappear or the virus becomes undetectable, the transmission picture remains uncertain. The CDC states plainly that it is not known how long a person can spread HPV after warts resolve. Given what we know about viral latency, it’s plausible that low-level viral shedding could continue for some time after clinical clearance, though the risk likely drops substantially.
Condoms reduce HPV transmission but don’t eliminate it, because the virus can infect skin that condoms don’t cover. There is no point at which a doctor can definitively tell you that you are no longer capable of transmitting the virus, largely because there’s no reliable way to test for it in men in the first place.